{"id":882,"date":"2026-10-26T10:08:58","date_gmt":"2026-10-26T08:08:58","guid":{"rendered":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/"},"modified":"2026-10-26T10:25:18","modified_gmt":"2026-10-26T08:25:18","slug":"building-a-payer-value-dossier-structure-evidence-and-local-adaptation","status":"publish","type":"post","link":"https:\/\/www.pqra.gr\/el\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/","title":{"rendered":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation"},"content":{"rendered":"<p style=\"font-size:19px;line-height:1.7;color:#33414d;\"><strong>A payer value dossier is not a regulatory dossier with a different cover. It answers a different question: not whether the medicine is safe and effective, but what difference it makes to patients and to the health system, compared with what is used today.<\/strong><\/p><h2>Start from the payer&#8217;s decision<\/h2><p>Payers and HTA bodies decide whether to reimburse, at what price and under what conditions. Your dossier should make that decision easy to reach. Build it backwards from the questions an assessor will ask, and write for a reader who is clinically literate but has limited time and no loyalty to your product.<\/p><h2>A workable structure<\/h2><ul><li><strong>Disease and unmet need:<\/strong> burden, current pathway of care and where the gap sits, using local data wherever possible.<\/li><li><strong>Product and positioning:<\/strong> the licensed indication, the intended place in therapy and the patients most likely to benefit.<\/li><li><strong>Clinical evidence:<\/strong> pivotal trials, relevant outcomes, safety and a candid account of limitations.<\/li><li><strong>Comparative evidence:<\/strong> head-to-head data where it exists, and indirect comparisons where it does not.<\/li><li><strong>Economic evaluation and budget impact:<\/strong> a model that traces from the evidence to cost and outcomes.<\/li><li><strong>Implementation:<\/strong> what the health system must do differently to use the product well.<\/li><\/ul><h2>Global core, local adaptation<\/h2><p>Most companies write a global value dossier once and adapt it market by market. That is efficient, but only if the global document is modular. Comparators, treatment pathways, unit costs, population size and accepted outcome measures all differ between countries. A dossier that cannot be re-cut quickly will be adapted badly, or late.<\/p><p>The EU joint clinical assessment, now applying to a widening set of products under the HTA Regulation, covers the clinical domain only. Pricing, reimbursement and the economic and organisational assessment remain national, so the local value story still has to be told in each market.<\/p><h2>Common weaknesses<\/h2><ul><li>Claims the evidence cannot carry, particularly on surrogate endpoints.<\/li><li>Comparators chosen for convenience rather than relevance to the local pathway.<\/li><li>Models that cannot be traced back to the cited data.<\/li><li>No honest treatment of uncertainty, which assessors then supply for themselves.<\/li><\/ul><h2>Plan the evidence early<\/h2><p>The most useful time to write a value dossier is before the pivotal trial is finalised. Gaps in comparators, patient-reported outcomes or follow-up are cheap to address in a protocol and expensive to explain afterwards. Early scientific advice, and joint scientific consultations where available, are the places to test these choices.<\/p><h2>A short checklist<\/h2><ul><li>Can every claim in the dossier be traced to a cited source?<\/li><li>Is the intended place in therapy consistent with the licensed indication?<\/li><li>Have local payers&#8217; own templates and evidence requirements been read, not assumed?<\/li><li>Is there a named owner for each market adaptation, with a realistic timeline?<\/li><\/ul><p>Answering these questions early turns the dossier from a late-stage writing exercise into a managed workstream, which is the difference between arriving at the payer&#8217;s door prepared and arriving explaining.<\/p><h2>How PQRA helps<\/h2><p>PQRA supports the regulatory and market access side of this work: reviewing the evidence plan against how payers actually assess products, structuring modular dossiers that can be adapted to national requirements, and aligning regulatory milestones with access timelines. We work with your HEOR and clinical teams rather than replacing them.<\/p><p>Ready to discuss your market access plan? <a href=\"\/el\/contact\/\"><strong>Contact PQRA<\/strong><\/a> to talk through your product and your target markets.<\/p>","protected":false},"excerpt":{"rendered":"<p>A payer value dossier is not a regulatory dossier with a different cover. It answers a different question: not whether the medicine is safe and effective, but what difference it makes to patients and to the health system, compared with what is used today. Start from the payer&#8217;s decision Payers and HTA bodies decide whether [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":987,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"saved_in_kubio":false,"_swpsp_post_exclude":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-882","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pqra.gr\/el\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA\" \/>\n<meta property=\"og:description\" content=\"A payer value dossier is not a regulatory dossier with a different cover. It answers a different question: not whether the medicine is safe and effective, but what difference it makes to patients and to the health system, compared with what is used today. Start from the payer&#8217;s decision Payers and HTA bodies decide whether [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pqra.gr\/el\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/\" \/>\n<meta property=\"og:site_name\" content=\"PQRA\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T08:08:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-26T08:25:18+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u03bb\u03b5\u03c0\u03c4\u03ac\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\"},\"headline\":\"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation\",\"datePublished\":\"2026-10-26T08:08:58+00:00\",\"dateModified\":\"2026-10-26T08:25:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/\"},\"wordCount\":562,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/payer-value-dossier-structure-evidence-local-adaptation.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/\",\"name\":\"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/payer-value-dossier-structure-evidence-local-adaptation.png\",\"datePublished\":\"2026-10-26T08:08:58+00:00\",\"dateModified\":\"2026-10-26T08:25:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/payer-value-dossier-structure-evidence-local-adaptation.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/payer-value-dossier-structure-evidence-local-adaptation.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pqra.gr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#website\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"name\":\"PQRA\",\"description\":\"Your trusted partner in Pharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pqra.gr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#organization\",\"name\":\"PQRA\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"contentUrl\":\"https:\\\/\\\/www.pqra.gr\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/pqra-logo-white.png\",\"width\":594,\"height\":362,\"caption\":\"PQRA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pqra.gr\\\/#\\\/schema\\\/person\\\/31e1a03125e7281efaddd7278681af2c\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.pqra.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pqra.gr\/el\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/","og_locale":"el_GR","og_type":"article","og_title":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA","og_description":"A payer value dossier is not a regulatory dossier with a different cover. It answers a different question: not whether the medicine is safe and effective, but what difference it makes to patients and to the health system, compared with what is used today. Start from the payer&#8217;s decision Payers and HTA bodies decide whether [&hellip;]","og_url":"https:\/\/www.pqra.gr\/el\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/","og_site_name":"PQRA","article_published_time":"2026-10-26T08:08:58+00:00","article_modified_time":"2026-10-26T08:25:18+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"admin","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"3 \u03bb\u03b5\u03c0\u03c4\u03ac"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#article","isPartOf":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/"},"author":{"name":"admin","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c"},"headline":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation","datePublished":"2026-10-26T08:08:58+00:00","dateModified":"2026-10-26T08:25:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/"},"wordCount":562,"commentCount":0,"publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"image":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/payer-value-dossier-structure-evidence-local-adaptation.png","articleSection":["Uncategorized"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/","url":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/","name":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation - PQRA","isPartOf":{"@id":"https:\/\/www.pqra.gr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#primaryimage"},"image":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/payer-value-dossier-structure-evidence-local-adaptation.png","datePublished":"2026-10-26T08:08:58+00:00","dateModified":"2026-10-26T08:25:18+00:00","breadcrumb":{"@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#primaryimage","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/payer-value-dossier-structure-evidence-local-adaptation.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/10\/payer-value-dossier-structure-evidence-local-adaptation.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.pqra.gr\/building-a-payer-value-dossier-structure-evidence-and-local-adaptation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pqra.gr\/"},{"@type":"ListItem","position":2,"name":"Building a Payer Value Dossier: Structure, Evidence and Local Adaptation"}]},{"@type":"WebSite","@id":"https:\/\/www.pqra.gr\/#website","url":"https:\/\/www.pqra.gr\/","name":"PQRA","description":"Your trusted partner in Pharma","publisher":{"@id":"https:\/\/www.pqra.gr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pqra.gr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/www.pqra.gr\/#organization","name":"PQRA","url":"https:\/\/www.pqra.gr\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/","url":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","contentUrl":"https:\/\/www.pqra.gr\/wp-content\/uploads\/2026\/07\/pqra-logo-white.png","width":594,"height":362,"caption":"PQRA"},"image":{"@id":"https:\/\/www.pqra.gr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pqra.gr\/#\/schema\/person\/31e1a03125e7281efaddd7278681af2c","name":"admin","image":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/656b750ec6bc02db9de84dc3080e82be722c7777ef23ff04d6e8e7a0ac541a45?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.pqra.gr"]}]}},"_links":{"self":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/comments?post=882"}],"version-history":[{"count":1,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/882\/revisions"}],"predecessor-version":[{"id":989,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/posts\/882\/revisions\/989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media\/987"}],"wp:attachment":[{"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/media?parent=882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/categories?post=882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pqra.gr\/el\/wp-json\/wp\/v2\/tags?post=882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}